AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
97 hedge funds and large institutions have $500M invested in Avadel Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
20% less capital invested
Capital invested by funds: $623M → $500M (-$122M)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
97
Holding in Top 10
6
Calls
$907K
Puts
$1.01M
Top Buyers
| 1 | +$17.4M | |
| 2 | +$16.6M | |
| 3 | +$13.4M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$9.51M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$8.47M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$8.63M | |
| 3 | -$6.66M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$5.67M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$4.96M |